Zobrazeno 1 - 2
of 2
pro vyhledávání: '"35"'
Autor:
W.-Y. Wong, F. Baghaei, Darby Stephens, Thynn Thynn Yee, Robert Numerof, Anne Lienhart, Claude Negrier
Publikováno v:
Haemophilia. 19:e143-e150
Factor VIII Inhibitor Bypassing Activity (FEIBA) can effectively achieve haemostasis in haemophilia patients with inhibitors. Further evaluation of FEIBA in surgical settings is of significant interest considering the relatively limited prospective d
Autor:
Kingsley Hampton, Steven R. Lentz, Chunduo Shen, Elena Santagostino, Karina Meijer, Anne T. Neff, Jameela Sathar, Alberto Tosetto, Andrea Landorph, László Nemes, Pratima Chowdary
Publikováno v:
Haemophilia, 26(3), 450-458. Wiley
Haemophilia
Haemophilia
Introduction Turoctocog alfa pegol is a glycoPEGylated recombinant factor VIII (FVIII) with an extended half‐life developed for prophylaxis, treatment of bleeds and perioperative management in patients with haemophilia A. Aim Evaluate the efficacy